CBO and the staff of the Joint Committee on Taxation (JCT) estimate that enacting H.R. 2813 would have insignificant effects on direct spending, revenues, and deficits over the 2023-2033 period. CBO and JCT’s analysis of state laws indicates that few states prohibit the sale of stop-loss coverage; thus, the bill’s preemption of state laws would affect only a small number of people.
H.R. 2813 would impose an intergovernmental mandate as defined by the Unfunded Mandates Reform Act (UMRA) by preempting any state laws that prevent certain group health plans from using stop-loss policies to insure against excess or unexpected claims losses. CBO estimates that the cost of the mandate would not exceed the intergovernmental threshold established by UMRA ($99 million in 2023, adjusted annually for inflation). The bill would not impose any private-sector mandates.